Filing Flows › Cardlytics (CDLX) › Q2 2026
Cardlytics (CDLX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
Cardlytics (CDLX) reported revenue of $36.9M for the second quarter 2026 (Q2 2026), -36% from a year earlier and +7% from the quarter before. Operating margin was -14.8%, net loss $14.9M (40.3% of revenue).
Cardlytics, Q2 2026: revenue $36.9M (-36% year over year), operating margin -14.8%, net loss $14.9M, operating cash flow −$8.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.9M | +7% | -36% |
| Operating profit | −$5.4M | — | — |
| Net earnings | −$14.9M | — | — |
| Operating cash flow | −$8.6M | — | -802% |
What changed
Revenue was $36.9M in Q2 2026, down 36% year over year and up 7% from the previous quarter. Engagement based pricing was the largest line at 65% of revenue. Engagement based pricing lost $12.0M year over year (down 33%), 57% of the total change.
Operating costs exceeded revenue by $5.4M, an operating margin of -14.8%. Total costs fell 37% while revenue fell 36%. The quarter ended with a net loss of $14.9M, wider than the previous quarter's $4.5M loss. Net interest and other expense of $9.4M was the main reason.
Operating cash flow was −$8.6M. Non-cash charges added back $4.1M of depreciation and amortization and $2.4M of share-based compensation. Capital expenditures of $2K exceeded it, leaving free cash flow of −$8.6M.
Questions
What was Cardlytics' revenue in the second quarter 2026?
Cardlytics (CDLX) reported revenue of $36.9M for the second quarter 2026 (Q2 2026), -36% from a year earlier and +7% from the quarter before.
Was Cardlytics profitable in the second quarter 2026?
Operating loss was $5.4M (-14.8% of revenue) and net loss $14.9M.
Source: Cardlytics 10-Q on SEC EDGAR.